BEAM
Price
$23.81
Change
-$0.51 (-2.10%)
Updated
Apr 19, 1:57 PM EST
18 days until earnings call
OCGN
Price
$1.32
Change
-$0.00 (-0.00%)
Updated
Apr 19, 6:59 PM EST
14 days until earnings call
Ad is loading...

Compare predictions BEAM vs OCGN

Header iconBEAM vs OCGN Comparison
Open Charts BEAM vs OCGNBanner chart's image
Beam Therapeutics
Price$23.81
Change-$0.51 (-2.10%)
Volume$2.09K
CapitalizationN/A
Ocugen
Price$1.32
Change-$0.00 (-0.00%)
Volume$3.98M
CapitalizationN/A
View a ticker or compare two or three
BEAM vs OCGN Comparison Chart

Loading...

BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
OCGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BEAM vs. OCGN commentary
Apr 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongSell and OCGN is a Hold.

COMPARISON
Comparison
Apr 19, 2024
Stock price -- (BEAM: $24.31 vs. OCGN: $1.32)
Brand notoriety: BEAM and OCGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 114% vs. OCGN: 71%
Market capitalization -- BEAM: $1.99B vs. OCGN: $339.67M
BEAM [@Biotechnology] is valued at $1.99B. OCGN’s [@Biotechnology] market capitalization is $339.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $553.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileOCGN’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • OCGN’s FA Score: 0 green, 5 red.
According to our system of comparison, both BEAM and OCGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 3 TA indicator(s) are bullish while OCGN’s TA Score has 3 bullish TA indicator(s).

  • BEAM’s TA Score: 3 bullish, 4 bearish.
  • OCGN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than OCGN.

Price Growth

BEAM (@Biotechnology) experienced а -10.85% price change this week, while OCGN (@Biotechnology) price change was -21.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.81%. For the same industry, the average monthly price growth was -5.21%, and the average quarterly price growth was +1226.26%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 06, 2024.

OCGN is expected to report earnings on Aug 02, 2024.

Industries' Descriptions

@Biotechnology (-6.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BEAM with price predictions.
OPEN
A.I.dvisor published
a Summary for OCGN with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BEAM($1.99B) has a higher market cap than OCGN($340M). OCGN YTD gains are higher at: 129.565 vs. BEAM (-10.691).
BEAMOCGNBEAM / OCGN
Capitalization1.99B340M584%
EBITDAN/AN/A-
Gain YTD-10.691129.565-8%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
OCGN: Fundamental Ratings
OCGN
OUTLOOK RATING
1..100
85
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMOCGN
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 30 days ago
81%
Bullish Trend 26 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Ad is loading...
BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
OCGNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RTDAX17.09-0.03
-0.18%
Russell Inv Multifactor US Equity A
MGPSX73.48-0.30
-0.41%
ProFunds Mid Cap Growth Svc
OEGIX31.17-0.21
-0.67%
Invesco Discovery Mid Cap Growth R6
BFGUX36.46-0.25
-0.68%
Baron Focused Growth R6
TSPTX6.52-0.05
-0.76%
Transamerica Small Cap Growth I3

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with NTLA. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
N/A
NTLA - BEAM
77%
Closely correlated
-0.84%
CRSP - BEAM
69%
Closely correlated
+1.08%
DNLI - BEAM
69%
Closely correlated
-1.31%
EDIT - BEAM
63%
Loosely correlated
-1.07%
PRME - BEAM
62%
Loosely correlated
-6.90%
More